| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113883.3.464.1003.1258 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1258/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1258 |
| Version | 20240124 |
| Status | active |
| Date | 2024-01-24T01:11:59-05:00 |
| Name | SubstanceUseDisorderLongActingMedication |
| Title | Substance Use Disorder Long Acting Medication |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this Grouping value set is to represent concepts for long acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable buprenorphine implant, buprenorphine injection and naltrexone injection medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes short acting oral and sublingual medications.) |
FHIR